35 S]sulfate into total and specific glycosaminoglycans of the liver of rats injured acutely by a singie intraperitoneal dose of either jD-galactosamine (700 and 350 mg/kg body weight, respectively) or thioacetamide (100 mg/kg body weight) was studied in vivo and in liver slices. Regardless of the chemical nature of the hepatotoxic agent and its mechanism of action the incorporation of isotope in vivo is changed biphasically: a rapidly occurring and strong Inhibition is followed by pronounced elevation in later stages of injury. In contrast to the dose-dependent Inhibition of heparan sulfate formation the production of chondroitin sulfate and dermatan sulfate is only slightly and for a rather short period of time diminished. The synthesis of the latter glycosaminoglycans is stimulated 3 to 4 fold 8 to 24 h after onset of liver damage, fhat of heparan sulfate about 2 fold. Impaired synthesis of heparan sulfate occurs before the elevation of the activities of aspartate aminotransferase, alanine aminotransferase, and leucine arylamidase in serum. The specific radioactivity of 3'-phosphoadenosine-5'-phosphosulfate remains nearly constant in galactosamine-damaged livers. Similar time-dependent changes of [ 3S S]sulfate incorporation into heparan sulfate, chondroitin sulfate and dermatan sulfate were measured in slices from livers injured in vivo for various times with -D-galactosamine or thioacetamide. Neither serum from normal nor galactosaniine-treated rats influences the total amount and the pattern of glycosaminoglycans synthesized in normal or injured liver slices. Hepatic glycosaminoglycan formation of 3.5 and 33 months old rats responds quantitatively and qualitatively in a simüar way to £>-galactosamine; 50% Inhibition is reached with about 80 mg/kg of the hepatotoxin. The Inhibition of heparan sulfate synthesis in early injured livers could not be reversed by addition of p-nitrophenyl-/3-Z)-xylopyranoside to the medium (final concentration l mmol/1), but in rats treated with diethyldithiocarbamate or the flavonoid (+)-cianidanol-3, prior to injection of Z)-galactosamine, a partial restoration of the diminished synthesis of total glycosaminoglycans and of heparan sulfate is achieved.
Introduction
The understanding of the metabolism of proteoglycans in liver is of great importance both from a physiological and pathobiochemical point of view. Normally the concentration of glycosaminoglycans, i.e. the polysaccharide side chains of proteoglycans, in liver is low (1-4), but they are metabolized at a rather high rate (5, 6) . Heparan sulfate, the preponderant type of glycosaminoglycan in liver (7, 8) occurs predominantly in the microenvironment of the cell, i.e. the external surface of the hepatocyte (6, (9) (10) (11) (12) and piay there control the exchange of metabolites, ions, fluids, and wateir, exert some effects on hepatocellular proliferation and may regulate the accessibility of cell surface receptors (13-15). The physiological significance of the galactosamine containing sulfated glycosaminoglycans (chondroitin sulfate, dermatan sulfate) in liver is not known.
The concentration of heparan sulfate and also of chondroitin sulfate and dermatan sulfate in the distal portion of the intercellular space increases dramatically in longterm damaged livers, leading to the fibrotic transition of the tissue (for recent reviews see (16) (17) (18) ). As discussed previously (17, 18) neither the cellular nor molecular pathobiochemical mechanism responsible for the accumulation of liver proteoglycans (and also of collagens) are well understood. The present work was undertaken to elucidate some principle features of glycosaminoglycan metabolism in acutely damaged livers which might be meaningful both for the pathobiochemistry of hepatocellular damage and for the pathogenesis of liver fibrosis, which develops if the hepatotoxic agent is applied continuously at a certain dose. Therefore the studies were performed in the early phases of two independent, well defined experimental models of liver disease, i.e. Dgalactosamine hepatitis (19-21) and thioacetamideinduced liver injury (22, 23) , which both result ultimately in liver fibrosis and cirrhosis (24) (25) (26) (27) .
carrier-free sodium [ 3S S J sulfate, 3^phosphoadenq:$ine-5'-phosphosuifate (tetrasodiiurn salt, 3'-[
35 S]), unlabeled glycosaminoglycans, chondroitin AClyase (EC 4.2.2.5), chondroitin ABC lyase (EC 4.2.2.4), papain (EC 3.4.22.2), harmol -' HC1, and thin-layer chromatogräphy plates (CEL 300-25). Puromycindihydrochloride was purchased from Boehringer, Mannheim, FRG; dimethylsulfoxide (analytical grade) was irom E. Merck AG., Darmstadt, FRG; diethyldithiocarbamic acid (sodium salt, lot. 79 C-0125) andp-nit pphenyl·J(^.D-xylopy anoside (lot. 88O 0487) were from Sigma ChemicalComp., St. Louis, USA; L- (4,5- 3 H]leucine was from New England Nüclear, Boston, USA, and pentobarbital (Neinbutal (pharrn.)) from Serva, H'ejdelberg, FRG. (+)Cianidariol-3 (lot, N 26473 / ,4 < ,5,7-tetrahydroxyflavanol) was kindly provided by Zyma GmfcH, Munich, FRG.
Treatment ofrats
Male Sprague-Dawley rats (Lippische Versuchstieranstalt, Extertal, FRG) weighing 200-300 g had free access to a Standard rat diet and water throughout the experimental period. Age-related studies were performed with 3.5 (bödy weight about 350 g) and 33 months old (body weight about 600 g) male Han<: Wistar rats (Zentralinstitut für Versuchstiere, Hannover, FRG); Betweerc 8:00 and 11:00 a.m. they were injeeted intraperitoneally either with jD-galactosamine or thioacetamide both freshly dissoived in 0.154 mol/l of NaCl (saune). The precise doses are given in the legends of the appropriate figures and tables. Control rats received a similar volume of NaCl alone. If the synthesis of liver glycpsaminpglycans was studied in vivo the rats received, at certain times after application of the toxic agent and 30 min prior decapitation, 3.7 MBq of [ 3S S)sulfate intraperitoneally. The liver was quickly excised, minced, washed in ice-cold phosphate-buffered saline and processed for the Isolation of labeled glycosämirioglycans äs described below.
If the liver was used for preparation of slices the animals were anaesthetized by intraperitoneal injection of pentobarbital (54 mg/ kg body weight). The livers were perfused in situ for 3 min with ice-cold phosphate-buffered saline at a flow rate of 30 ml/min.
Preparation and incubation of liver slices
In principle the procedure described in detäil previously was applied (5) . In brief, slices of 0.5 mm thickness (about 100 mg wet weight) were prepared manually and ineubaled for 3 h at 37 °C and 90 oscillations/min in 3 ml ofDulbeccos modifieation of Eagles medium (pH 7.4) under C^-COi mixture, volume fraction 0.95/0.05. 0.93 MBq (50, ) öf [
35 S]sulfate were added at the beginning of the incubation. At the end, the slices were washed briefly in ice-cold buffered saline and transfered immediately into about 10 ml of cold acetone.
Materials and Methods
The commercial sources and specifications of the following materials and reagents have been described previously (4, 28) Preisänderungen vorbehalten t he Lowry proceduie, using bovine serum albumin s a Standard (30) . In vivo labeled, defatted and dried tissue was weighed prior to Suspension in buffered papain. The tissue was exhaustively proteolysed with papain (5) . From the proteolysed, trichloroacetic acid-soluble, and dialysed material [ 3S S Habeled giycosaminoglycans togcther with added unlabeled glycosaminoglycans s carrier were precipitated with cetylpyridinium Chloride s described previously (5) . The radioactivity of the isolated glycosaminoglycans was measured and refered to defatted liver dry weight (in vivo experiments) and protein (in vitro). For differentiation of specific types, the unfractionated glycosaminoglycans were subjected to enzymatic degradation with chondroitin AC and ABC lyases to yield the incorporation of | 3S SJsulfate into chondroitin 4,6-sulfate and dermatan sulfate, respectiveiy. They were also degraded with nitrous acid to measure the heparan | 3S S]sulfate (5) . Synthesis of specific glycosaminoglycans is expressed either in absolute terms (Bq/g protein), or relatively s a fraction of total glycosaminogiycan synthesis.
Determination offne concentration and speciflc radioactivity of 3'-phosphoadenosine-5'-phosphosulfate (PAPS) in liver
Concentration and specific radioactivity of PAPS in normal, galactosamine-and thioacetamide-damaged livers were assayed by the fluorimetric procedure ofPing Wong & Yeo (31) modified slightly s previously reported (28) . For this purposc an aliquot of the [ 35 SHabeled liver was pulverized in liquid nitrogcn from which PAP[ 3S S1 was extracted with Chloroform. In the presencc of a dog liver 178,000 £ supernatant the PAPS-bound ( 3s SJsulfatc is transfcred quantitatively to harmol. Labeled harmol sulfate was separated from harmol by thin-layer chromatography and quantitated s reported (28) .
Measurement ofthe incorporation of L-[*\l]leucine into protein of liver slices
Slices from normal and injured livers were incubated for 3 h at 37 °C in Dulbeccos medium containing 0.19 MBq of L- [4, H]-leucine. At the end of incubation the slices were quickly washed in ice-cold buffer, boiled for 3 min, dried, and homogenized in 2 ml of destilled water from which an aliquot was taken for the determination of protein (30) . 100 μΐ portions of the homogenate were spotted ori Whatman 3 MM filter paper disks and sequentially extracted according to the technique ofMans & Novelli (32) . The incorporation of [ 3 H]leucine is refered to the protein content of the slice.
Cottecti n ofblood and determination of serum enzyme activities
Blood was aspirated from the V. cava inf. of the anaesthetized rat and nonhaemolytic serum prepared. The activities of alanine aminotransferase (EC 2.6.1.2) (33), aspartate aminotransferase (EC 2.6.1.1) (34) and leucine arylamidase (EC 3.4.11.) (35) were measured. The first two were determined in a DuPont Automatic Clinical Anajyzer, the latter in the Eppendorf enzyme a tomate ACP 5040. The serum used for incubation studies was prepared freshly and stored in -ice until use. 
Results

Synthesis of glycosaminoglyeans in acutely injured rat liver in vivo
In response to the administration of a single dose of D-galactosamine (350 mg/kg body weight) to rats the incorporation of [ 3S S]sulfate into total liver glycosâ minoglycans is depressed fapidly and to a great extent (flg. l a). 30 min after induction of liver injury the incorporation is reduced by about 75% reaching the lowest values after 2 h. Later on the rate of incorporation increases gradually and climaxes between 24 and 48 h. At this time the labeling of glycosaminoglycans is nearly twice that found in the respective control livers. 3 to 4 days after application ofthe drug [ 35 S]sulfate ίηΰΟφΟΓ-ation into glycosaminoglycans is similar to fhat in normal livers.
Qualitatively similar biphasic changes were found for the production of heparan [ 3S S]sulfate (fig. Ib) but its Inhibition takes longer and is more severe (nearly complete Inhibition between 0.5 and 4 h) and its Stimulation is less than that of total glycosaminoglycans. This observation suggests that the production of the other types of sulfated glycosaminoglycans, i.e. of chondroitin sulfate and/or dermatan sulfate, is differently affected in iniured livers. Figure Ic and Id substantiate that the incorporation of [ 35 S]sulfate into diese types of glycosaminoglycans is inhibited only for a short period and to a small extent when compared to heparan sulfate. Instead, their synthesis is greatly, i.e. 3-to 4-fold exaggerated S to 24 h after induction of liver damage. At a time point (4 h) when heparan sulfate production is nearly completely depressed, the incorporation of [ 3S S]sulfate into chondroitin sulfate is 2 times that measured in control livers.
The duration of the inhibitory phase is dose-dependent; with 700 mg/kg of Z)-galactosamine the Inhibition of heparan [
35 S]sulfate synthesis is extended to 3 days, that of total glycosaminoglycan production to l day (not shown). This; again, indicates a strong Stimulation of the formation of the remaining types of glycosaminoglycans (chondroitin sulfate, dermatan sulfate) between 1 and 3 days after onset of injury.
The specific radioactivity of liver 3'-phosphoadenosine-5'-phosphosulfate (PAPS) does not change significantly in D-galactosamine-injured rat liver, although its concentration in the tissue was found to be reduced by 50% 2 days after initiation of liver damage (tab. 1). Thus, the changes in the rates of incorporation of [ 3S S] sulfate into glycosaminoglycans observed in injured liver seem to be a true reflection of the biosynthesis of these complex glycoconjugates.
Acute thioacetamide-induced liver damage (100 mg/kg body weight), resulted in biphasic changes of total and specific hepatic glycosaminoglycan synthesis, qualitatively very similar to those described for galactosamine (results not shown). Thus, the changing pattern of glycosaminoglycan synthesis obviously is not related to the chemical nature and the mechanism of action of the hepatotoxic compound.
Synthesis of glycosaminoglycans in slicesfrom livers injured in vivo with D-galactosamine or thioacetamide
The time-dependent changes of the synthesis pattern of sulfated glycosaminoglycans were studied in more detail in slices derived from in vivo preinjured livers, thus eliminating in pari possible influences of extrahepatic factor^s. In accordance with the in vivo results ( fig. 1 ) slices from galactosamine-damaged liver (350 mg/kg body weight) show a strong impairment of their glycosaminoglycan synthesis between 0.5 and 6 h after onset Tab. l. Conccntration and specific radioactivity of 3'-phosphoadcnosine-5'-phosphosulfate in rat liver following administration of Z)-galactosaminc. fig. 2b ), Its depression, however, is more severe than that of total glycosaminoglycans which is due to an additional decline in the relative proportion of heparan [ 3 *S]-sulfate production. Normally this glycosaminoglycan represents a fraction of about 0.85 of total glycos·: aminoglycan synthesis but in injured liver its portion is only about 0.5 ( fig. 2b) . The loss of heparan sulfate is "compensated" by a strong relative increase in the production of both chondroitin sulfate and dermatan sulfate ( fig. 2c ). The incorporation of [ 3S S] sulfate into these polysaccharides is only slightly and for a short period of time reduced, but a 3-fold (dermatan sulfate) and a nearly 5-fold (chondroitin sulfate) Stimulation were observed after 24 to 48 h ( fig. 2c) . Compared with the time-course of the incorporation of [ 3 H}leucine into total protein during the first 6 h after gatactosamimeprovoked liver damage, the formation of chondroitin sulfate and derrriatan sulfate, in contrast to that of heparan sulfate, seems to be rather independent of protein synthesis ( fig. 2a, inset) .
The time-course öf[
35 S]sulfate iiicorporation into total glycosaminoglycans in slices prepared from liver in the state of low (time of injury 4 h) or high (time of injury 48 h) glycosaminoglycan synthesis indicates that the incorporation in the latter is linear only up to 6 h, whereas the förmer (and control liver slices) exhibits linearity at least up to 8 h of incubation ( fig. 3a) . It is irnportant to note that the fraction of heparan [
35 S]sulfate is not influenced by the time of incubation, and is only dependent on the duration of injury, i.e. in the early injured liver the portion of heparan sulfate is smallest (0.55 instead of 0.8 in control liver slices, fig. 3b ). The incorporation of ( 35 S)sulfate into glycosaminoglycans of liver slices from galactosamine-treated rats is expressed äs the proportion of that of control livers incubated under identical conditions. Each time point is the mean value of 3 experiments, the CV was within 15%, The relative incorporation into total glycosaminoglycans (a), heparan sulfate (b), dermatan sulfate (c, ·-·), and chondroitin sulfate (c, ·-·). is shown. In (b) heparan sulfate is expressed also äs fraction of total labeled glycosaminoglycans (*-A ). The inse-t in (a) reprcsents the incorporation of | 3 H]leucine into total protein of slices from livers treated for various times with 350 mg/kg body weight of /)-galactosamine, expressed äs fraction of that measured in the respective control liver slices.
Total and specific glycosaminoglycan synthesis in slices from acute thioacetamide-injured livers behaves similarly to that in galactosamine-damaged tissue (flg. 4). There is fig. 4b ). It shouid be emphasized that the depression of liver heparan sulfate synthesis bccurs before the activities in serum of alanine aminotransferase, aspartate aminotransferase, and leucine arylamidase increase ( fig. 4b) . The relationship between the synthesis of glycosaminoglycans and incorporation of [ 3 H]leucine into protein ( fig. 4c ) is identical to that described for galactosamine hepatotoxicity. 
Effect ofage ofthe rat on galactosamine-induced Inhibition of liver glycosaminoglycan synthesis
The sensitivity of hepatic glycosaminoglycan formation to Z)-galactosamine was tested in relation to the age of the rat. No significant differences were found in the 
Effect of serum from normal and injured rats on the synthesis of glycosaminoglycans in slices from normal and injured liver
To define possible humoral regulators of hepatic glycosaminoglycan synthesis, slices from normal and diseased liver were iiicubated in the presence or absence öf serum from normal and injured rats. Results surnmärized in into glycosaminoglycans of normal liver slices is not affected by serum from either normal rats or animals injured for various times withß-galactosamine. Both the fraction and the total amount of heparan sulfate synthesized are also unsusceptive to serum. The biphasic modulation of formation of total glycosaminoglycans in slices from livers injured for various times with Z?-galactosamine is not significantly influenced by serum from either normal or injured rats, which is also true for the synthesis of heparan sulfate, chondroitin sulfate, and dermatan sulfate (tab. 2). Thus, neither the inhibitory nor the stimulatory phase of liver glycosaminoglycan production seems to be mediated by factor(s) residing in the serum (see also fig. 2 ).
Action of p-nitrophenyl-fl-D-xylopyranoside on galactosamine-induced Inhibition of [ 3S S]sulfate incorporation into total liver glycosaminoglycans
From the results described in figure 2 and 4 it can be deduced that the Inhibition of heparan sulfate synthesis miglit be due to a depression of the production of the core protein moiety of the proteoglycan. Consequently, the introduction of an artificial polysaccharide chain acceptor molecule into the cells, e.g./?-nitrophenyl-0.D-xyloside, should partially overcome galactosamine-induced Inhibition of glycosaminoglycan synthesis. It was found (tab. 3) that in the presence-of l mmol/1 p-nitrophenyl-ß-£)-xyloside the formation of total glycosaminoglycans and of heparan sulfate is reduced to 0.70 of that measured in slices incubated in the absence of this compound. Under conditions of nearly complete Inhibition of total glycosaminoglycan synthesis (0.5 mmol/1 puromycin) p-nitrophenyl-0-Z)-xyloside is able to increase [ 3S S]sulfate incorpoiation about 2.5 fold. However, the Inhibition of heparan sulfate production induced by l mmol/1 of £>-galactosamine (0.24 of control) is not partially reversed by p-nitrophenyl-|3-Z)-xyloside; instead, a further slight decüne, similar to that measured in untreäted liver slices, was found (tab. 3). Thus, the results do not support the view that diminished core protein synthesis is the only mechanism of action of £)-galactosamine on hepatic glycqsajninoglycan synthesis.
Effects of diethyldithiocäfbafnate and of(+)cianidanol~3 on the Inhibition of glycosaminoglycan synthesis in galactosamine-injured liver
Pretreatment of rats with a single dose of diethyldithiocarbamate (300 mg/kg bpdy weight) results in a partial reversibüity of the Inhibition of [ 35 S].sulfate incorporation into total liver glycosaminoglycans produced by D-galactosamine (tab. 4). In addition, the "hepatoprotective" coinpound elevates the diminished fraction of heparan [ 35 S] sulfate in diseased liver from 0.52 to 0.69. Thus, heparan sulfate synthesis in acutely,/*· galactosamine-damaged livers is increased over 6-fold If total glycosaminoglycan production is more severely inhibited the protective capacity of the flavonoid is more pronounced and equals that of diethyldithiocarbamate (not shown).
Discussion
The results presented in this study indicate clearly biphasic temporal changes in the incorporation of [
35 S]-sulfate into various types of liver glycosaminoglycans. The rate of isotope incorporation probably equals the rate of carbohydrate chain synthesis since there was no significant change in injured liver of the specific radioactivity of the immediate precursor of glycosaminoglycan sulfation, S'-phosphoadenosine^'-phosphosulfate, and it has not been shown so far, that sulfate groups of liver glycosaminoglycans turn over independently from the carbohydrate chain backbone. The cyclic modulation of the synthesis of sulfated liver proteoglycans in response to acute injury obviously is qualitatively independent of the type and mechanism of action of the noxious agent, which is true at least for ß-galactosamine and thioacetamide, but likely also for others (e.g. carbon tetrachloride, dimethylnitrosamine). Thus, the scheme presented in figure 5 can probably be generalized for a variety of acute, toxic liver injuries.
The Inhibition of the synthesis of proteoheparan sulfate observed in the first phase ( fig. 5 ) might play a pivotal role in the multistep process of liver cell damage (36) or, in the Initiation of cell division following injury (37) . Both assumptions arise from the previously discussed (28) and above briefly mentioned physiological functions of pericellular proteoheparan sulfate (6, (9) (10) (11) (12) . In addition to the key role of changes of the plasmalemma in the pathogenesis of toxic liver injury (38) (39) (40) (41) the loss of the coordtnate exchange of metäbolites and ions across the cellular barrier which is an early sign of cellulaf damage.
Under the protective effects of diethyldithiOcarbamate (42) and of the natural flavonoid (*)cianidanol-3 (43-45) on the development of galactosainine-hepar titis, a less pronoünced Inhibition of proteogiycan synthesis was observed. Clearly, the experiments do not decide whether this resuit is ä consequence of less severe hepatic damage or vice versa.
As already mentioned depletion of cell surface proteoheparan sulfate might trigger the proliferation of liver cells probably by facilitäting the influx of cell-surface, membrane associäted Ca 2+ into the cytosol (46) . A transient increase in cytosolic free Ca 1 "" 1 " appears to be required for enhanced proliferative tendency of normal and transformed cells (47) . Thüs, changes in the composition of sulfated glycosaminoglycans result in differences in the metal ion bindijig/release characteristics and by this might affect the intraeellular availability of pericellular Ca ?+ (48) . In accordance with this assumption we found recently deminished synthesis of proteoheparan sulfate in regenerating rat liver (49) . UndOubtedly, more detailed studies on the cell coat of isoiated membränes from preinjured liver cells are required to solve these Problems.
The biochemical mechanisms uriderlying the Inhibition of synthesis of proteoheparän sulfate and to some degree of chondroitin sulfate and deimatan sulfate are not eleaf. From previoüs results (28) it was assumed that diminished eore protein synthesis öf proteoheparan sulfate might be crucial, ä Suggestion, which is indirectly supported here by showing the parällelism of ijgJübited proteogiycan and general protein synthesis in early stäges of liver injury. However, we failed to counteract galactosamine-in o duced iriMbition of heparan sulfate synthesis withp-nitrophenyl-j3-jD-xyloside, an attificial acceptor of the polysaccharide chains (50, 51) , whereas in puromycin-treated slices a slight improvement was achieved. The latter finding confirms previous results which show partial restoration of hepatocellular heparan sulfate synthesis by p-nitrophenyl-j3-/)-xyloside in the absence of protein synthesis (52) . If technical reasons for this failure are excluded, one might assurne that proteoglycan synthesis in galactosamine-damaged liver is impaired (also) at later biosynthetic Steps, e.g. at the level of chain initiation and/or elongation.
The stimulated synthesis of proteoglycans in later stages of acute injury ("overshoot" phenomenon of the second phase in fig. 5 ) deserves special interest since it may represent initial biochemical features of a process leading to active accumulation of glycosaminoglycans during long-term injury (27) . It is of importance that the synthesis of chondroitin sulfate and dermatan sulfate, which are the preponderant types of sulfated glycosaminoglycans in fibrotic liver tissue (2, 53) , is mostly exaggerated. The cellular source of chondroitin sulfate and dermatan sulfate synthesis needs to be clarified before any conclusive studies on the molecular mechanisms of disease-associated Stimulation can be made. Since the hepatocyte synthesizes nearly exclusively chondroitin ABC-lyase-resistant glycosaminoglycans (6,9, 54) the biosynthetic capacity of non-parenchymal liver cells (mainly sinusoidal lining cells) and of infiltrated in-. flammatory cells, e.g. or polymorphonuclear leucocytes and monocytes (55) has to be analysed.
A great variety of metabolic processes in the liver are controlled by humoral factors of hormonal and nonhormonal nature. The effect of serum factors on proteoglycan synthesis in other Systems than liver, e,g. in embryonic cartilage, is well documented (56) (57) (58) (59) . Amazingly, neither Inhibition and Stimulation of total hepatic glycosaminoglycan synthesis nor the pattern of specific types was found to be affected by serum from normal or from injured rats. Thus glycosaminoglycan formation in liver explants in short-term culture seems to be refractory to the action of serum mediators. Possible reasons might be the relative short incubation period, saturating intracellular concentrations of the mediators during the time of incubation, a rapid inactivation of the serum factors in vitro or, less likely, an unresponsiveness of liver cells to the respective serum components. The former reasons might explain, why, in monolayer cultures of rat hepatocytes, heparan sulfate synthesis is strongly reduced in the presence of fetal calf serum (observation mentioned in I.e. (54)). 
